2seventy bio, Inc.

NasdaqGS:TSVT Stock Report

Market Cap: US$162.0m

2seventy bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TSVT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Nov 24SellUS$13,182Marcela MausIndividual3,900US$3.38
03 Oct 24SellUS$5,718Victoria EatwellIndividual1,230US$4.65
03 Oct 24SellUS$3,157Jessica SnowIndividual679US$4.65
14 Aug 24SellUS$33,760Jessica SnowIndividual7,816US$4.32
05 Aug 24SellUS$52Victoria EatwellIndividual13US$3.99
02 Jul 24SellUS$48Victoria EatwellIndividual12US$4.02
02 Jul 24SellUS$56Jessica SnowIndividual14US$4.02
03 Jun 24SellUS$2,714Jessica SnowIndividual649US$4.18
03 Jun 24SellUS$4,881Victoria EatwellIndividual1,167US$4.18
03 May 24SellUS$74Jessica SnowIndividual15US$4.91
26 Mar 24BuyUS$203,992Casdin Capital, LLCCompany40,000US$5.10
25 Mar 24BuyUS$3,899,050Casdin Capital, LLCCompany777,377US$5.12
05 Jan 24SellUS$5,833Nick LeschlyIndividual1,554US$3.75
05 Jan 24SellUS$2,984Philip GregoryIndividual795US$3.75
05 Jan 24SellUS$5,180William BairdIndividual1,380US$3.75
03 Jan 24SellUS$279,739Nick LeschlyIndividual72,312US$3.87
03 Jan 24SellUS$130,179William BairdIndividual33,651US$3.87
03 Jan 24SellUS$99,084Philip GregoryIndividual25,613US$3.87

Insider Trading Volume

Insider Buying: TSVT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TSVT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,493,7802.9%
General Public4,579,2078.88%
Hedge Funds5,953,82511.5%
Institutions39,561,60876.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 81.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.5%
Kynam Capital Management, LP
5,953,825US$18.7m0%1.42%
8.09%
Goldman Sachs Group, Investment Banking and Securities Investments
4,173,847US$13.1m1.93%0.01%
7.5%
BlackRock, Inc.
3,870,096US$12.2m5.71%no data
7.31%
The Vanguard Group, Inc.
3,772,232US$11.8m3.94%no data
5.45%
Morgan Stanley, Investment Banking and Brokerage Investments
2,813,087US$8.8m-11.5%no data
4.97%
Madison Avenue Partners, LP
2,563,222US$8.0m0%0.55%
4.92%
Newtyn Management, LLC
2,540,000US$8.0m2.21%0.86%
4.84%
Baker Bros. Advisors LP
2,497,526US$7.8m0%0.07%
3.88%
Casdin Capital, LLC
2,000,000US$6.3m0%0.39%
2.58%
Deutsche Asset & Wealth Management
1,330,950US$4.2m-25.4%no data
2.5%
Engine Capital Management, LP
1,289,949US$4.1m-13.7%0.54%
2.28%
Geode Capital Management, LLC
1,176,244US$3.7m1.13%no data
2.05%
State Street Global Advisors, Inc.
1,058,773US$3.3m1.5%no data
1.93%
Eversept Partners, L.P.
998,079US$3.1m-9.9%0.25%
1.55%
Cowen Inc,Private Banking and Investment Banking Investments
800,000US$2.5m0%0.07%
1.43%
Nick Leschly
736,599US$2.3m0%no data
1.22%
Dafna Capital Management, LLC
630,029US$2.0m-40%0.5%
1.17%
Bank of America Corporation, Asset Management Arm
602,408US$1.9m-0.59%no data
1.14%
Healthcare of Ontario Pension Plan
590,000US$1.9m-59.8%no data
1.02%
Venator Management LLC
525,000US$1.6m8.25%0.43%
0.96%
JP Morgan Asset Management
493,546US$1.5m-3.53%no data
0.91%
Marshall Wace LLP
468,883US$1.5m-29.7%no data
0.8%
Charles Schwab Investment Management, Inc.
413,599US$1.3m-7.94%no data
0.78%
Northern Trust Global Investments
402,613US$1.3m-2.74%no data
0.75%
Pleasant Lake Partners LLC
388,416US$1.2m0%0.17%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 17:55
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

2seventy bio, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John NewmanCanaccord Genuity
Samantha Lynn SemenkowCitigroup Inc
Samantha Lynn SemenkowCitigroup Inc